All Université de Montréal articles
-
NewsA molecule opens a breach in HIV, providing access to its reservoirs
An international team has unveiled how a molecule capable of opening the “shell” of HIV improves the elimination of infected cells. The study demonstrates how a new CD4-mimetic compound, CJF-III-288, modifies the HIV envelope protein structure to allow for a better immune response.
-
NewsThe RESTART trial: a drug to block a toxic HIV molecule
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even with antiretroviral treatment? Researchers will explore this in a groundbreaking clinical trial this fall.
-
NewsTinkering with the ‘clockwork’ mechanisms of life
Scientists have successfully recreated and validated two distinct mechanisms that can program both the activation and deactivation rates of nanomachines in living organisms across multiple timescales.
-
NewsAn antidiabetic helps the immune system recognize reservoirs of HIV
Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral therapy, a new study reveals.
-
NewsHIV: Thwarting a protein in the hope of a better quality of life
The sustained activation of the body’s immune system for people living with HIV leads to chronic inflammation that can cause associated complications such as cardiovascular diseases, osteoporosis or neurocognitive decline.
-
NewsTwo autopsies reveal secrets of HIV reservoirs
A research team shows for the first time that HIV reservoirs are concentrated in the spleen and lymph nodes, and that they can travel throughout the body.
-
NewsInfectious SARS-CoV-2 isolated from hospital air samples
Scientists have succeeded in isolating infectious particles of the SARS-CoV-2 virus from air samples collected from hospital rooms of COVID-19 patients and kept frozen for more than a year, a new study shows.